Muscle & Performance

Follistatin-344

A naturally occurring protein that inhibits myostatin and activin, promoting dramatic muscle growth.

Protein — varies by glycosylationHalf-life: 35–38 hoursMolar mass: 37000.00 g/mol

Community Rating

No ratings yet

Compound Profile

Follistatin-344

Key Data

FormulaProtein — varies by glycosylation
Molar mass37000.0 g/mol
Half-life35–38 hours
CategoryMuscle & Performance

Research reference only

Research Focus

Inhibits myostatin — removes the ceiling on muscle growth
Dramatically increases muscle mass and strength
Promotes satellite cell proliferation for muscle repair

Preclinical data

⚠ Research & Educational Use Only. Follistatin-344 is a research chemical documented here for scientific education. All information references peer-reviewed literature and preclinical/clinical study data. Not for human consumption. Not medical advice. Consult a licensed researcher or healthcare professional before any laboratory use.

Chemistry review: Ashish KumarWritten by the KnowYourPeptide Research TeamLast updated August 2026
Our editorial standards →
Key Takeaways
  • Inhibits myostatin — removes the ceiling on muscle growth
  • Dramatically increases muscle mass and strength
  • Promotes satellite cell proliferation for muscle repair
  • Follistatin-344 is not FDA-approved for human use. It is a research chemical for scientific study only.

Research At a Glance

  • Inhibits myostatin — removes the ceiling on muscle growth
  • Dramatically increases muscle mass and strength
  • Promotes satellite cell proliferation for muscle repair
  • Reduces body fat through metabolic effects
Calculate Follistatin-344 dose
Who researches this:Researchers studying myostatin inhibition and its effects on skeletal muscle hypertrophyThose investigating TGF-beta superfamily signaling in muscle tissuePeople researching genetic and peptide-based approaches to muscle mass regulationScientists studying the biology of muscle wasting conditions like muscular dystrophy
💡

In Plain English

Simple summary

Follistatin-344 is a naturally occurring isoform of follistatin, a glycoprotein your body produces to bind and neutralize myostatin -- the protein that actively limits how much muscle you can build. Myostatin is essentially a biological governor on muscle growth; animals born without functioning myostatin develop dramatically enlarged muscles. Follistatin-344 is studied because it blocks myostatin and other members of the TGF-beta superfamily, potentially removing that governor. A single study in non-human primates (the Iskander 2006 paper) showed significant muscle mass gains after intramuscular injection of a follistatin gene therapy, which became widely cited in bodybuilding contexts despite being a gene therapy study, not a peptide injection study.

  • Inhibits myostatin — removes the ceiling on muscle growth
  • Dramatically increases muscle mass and strength
  • Promotes satellite cell proliferation for muscle repair

The full scientific detail, mechanisms, citations, and dosing data, follows below.

What is Follistatin-344?

Tap any underlined term for an instant definition.

Follistatin-344 is a naturally occurring glycoprotein and one of the most potent muscle-building compounds studied. It works primarily by binding to and inhibiting myostatin (GDF-8) and activin, two proteins that act as negative regulators of muscle growth. By blocking myostatin, follistatin removes the body's natural brake on muscle hypertrophy, enabling significantly greater muscle growth than would otherwise be possible. Research in both animals and humans has shown remarkable results — in some gene therapy studies, subjects experienced 15–20% increases in muscle mass within weeks. It also plays roles in follicle-stimulating hormone regulation and neural development.

By the Numbers

Myostatin inhibitor
Follistatin-344 binds myostatin with high affinity, neutralizing the primary protein that limits muscle growth
100–150% muscle gain
Non-human primate gene therapy study (Iskander 2006) showed dramatic muscle increases -- note: this was gene therapy, not peptide injection
TGF-beta family
Follistatin inhibits multiple TGF-beta superfamily members including activin A, GDF-11, and BMP-2 alongside myostatin

Key Research Benefits

Documented effects observed in preclinical and clinical studies on Follistatin-344. See all Muscle & Performance peptides for comparison.

Inhibits myostatin — removes the ceiling on muscle growth
Dramatically increases muscle mass and strength
Promotes satellite cell proliferation for muscle repair
Reduces body fat through metabolic effects
Enhances recovery from exercise
May support bone density
Shown to reverse muscle wasting in animal models of muscular dystrophy

Common Stacks

Follistatin-344 is frequently combined with the following peptides for synergistic effects. Click any peptide to compare profiles before deciding.

Follistatin-344 removes the myostatin brake on muscle growth while IGF-1 LR3 provides the direct anabolic signal for hypertrophy and hyperplasia.

IGF-1 LR3 profile

Follistatin-344 removes the myostatin brake on muscle growth while Ipamorelin provides the GH signal to drive anabolism.

Ipamorelin profile

CJC-1295 sustains elevated GH output, complementing Follistatin-344's removal of growth-limiting factors.

CJC-1295 profile

Side Effects & Risks

Adverse effects reported in the research literature. All data sourced from preclinical and clinical study reports. View all peptides' side effects →

Dosing Data from the Literature

Doses referenced below are sourced from published preclinical and clinical studies. Use the peptide dose calculator to convert these values to injection volume.

Research Dosing Protocol

Research dosing: 100 mcg per day for 10 days (common protocol). More aggressive protocols use 300–500 mcg total over 5–7 days. Due to limited human research, caution is strongly advised. Not recommended for extended or repeated use without thorough understanding of risks.

Enter your vial size and target dose to get the exact injection volume.

Administration in Research Settings

Standard reconstitution and administration methodology for laboratory research use.

with . Intramuscular injection into target muscle groups may produce localized effects, while produces more systemic effects. Use the minimum effective dose. Long breaks between cycles are essential.

What the research doesn't show

The dramatic muscle-building results people cite almost always refer to the Iskander gene therapy study, where follistatin was delivered genetically to muscle cells -- a fundamentally different mechanism than injecting the peptide. Injected follistatin-344 has a short half-life and faces significant barriers to reaching muscle tissue at useful concentrations. The actual peptide injection literature is sparse. Managing expectations here is important.

Research Video

Medical Expert Videos

Physicians, researchers, and pharmacologists explain Follistatin-344, covering mechanisms of action, clinical context, and study findings.

YouTube, Follistatin-344 · doctors & researchersOpen in YouTube

Videos sourced from YouTube search. KnowYourPeptide does not endorse any individual creator. For research education only.

📋

The Bottom Line

Follistatin-344 has a growing body of preclinical evidence and a well-characterised safety profile in research settings. The most-studied application is: inhibits myostatin — removes the ceiling on muscle growth.

The most commonly reported side effect in research subjects is limited human research — long-term safety profile not fully established. It is a research chemical, not approved for human use.

Research chemicalNot for human useEducational purposes only

Frequently Asked Questions

Explore Further

Quick Reference

Half-Life
35–38 hours
Molar Mass
37000.00 g/mol
Formula
Protein — varies by glycosylation
Legal Status
Research chemical — not FDA approved for human use. Legal for research purposes in most jurisdictions. Banned by WADA in competitive sports.
Storage
Lyophilized: -20°C for long-term storage. Reconstituted: 2–8°C for 5–7 days. This protein is more fragile than smaller peptides — handle with care, avoid excessive agitation.

How It Compares

Myostatin inhibitor antibodies (like anti-myostatin therapies in clinical development) are the pharmaceutical route to the same goal. ACE-031 (activin receptor fusion protein) blocks the same pathway more broadly. Follistatin-344 is a naturally occurring protein rather than a designed drug, which gives it different distribution and stability characteristics.

Compare Follistatin-344 side-by-side

Research Use Only

This information is for educational research purposes only. This is not medical advice. Consult a qualified healthcare professional.

AI Peptide Advisor

online · Claude + Gemini
ask your question...